Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the shares of Common Stock, $0.10 par value, of Nabi Biopharmaceuticals. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: June 29, 2012
THE MANGROVE PARTNERS FUND, L.P. | |||
By: | MANGROVE CAPITAL, | ||
General Partner | |||
By: | /s/ Nathaniel August | ||
Name: | Nathaniel August | ||
Title: | Director | ||
MANGROVE PARTNERS | |||
By: | /s/ Nathaniel August | ||
Name: | Nathaniel August | ||
Title: | Director |
MANGROVE CAPITAL | |||
By: | /s/ Nathaniel August | ||
Name: | Nathaniel August | ||
Title: | Director |
/s/ Nathaniel August | |
NATHANIEL AUGUST |